Levima Advanced Materials Corporation (003022.SZ)
Beijing, CN
Based in Beijing, China, Levima Advanced Materials Corporation specializes in the innovation, production, and global distribution of sophisticated materials and specialized chemical compounds. Its comprehensive product range features premium EVA copolymers, custom-developed polypropylene materials, ethylene oxide and its various derivatives, in addition to polycarboxylate water reducers and nonionic surfactants. These offerings are widely utilized across numerous industries, including plastics manufacturing, solar energy (photovoltaic applications), cabling, household consumer goods, textiles, construction and infrastructure (encompassing roads and bridges), leather processing, and paints/coatings. The company maintains an expansive international sales network, distributing its products throughout China, the United States, European countries, the African continent, and various Southeast Asian nations. Furthermore, Levima Advanced Materials provides extensive customer support, which includes pre-sales consultation, technical assistance, logistics coordination, and thorough post-sale services.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.09% | +1.93% | -1.20% | +16.77% | +28.11% | +25.14% | +61.50% | -0.68% | -2.82% | +95.35% | +95.35% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+1.0% Q1'26: +45.9% (vs Q1'25)
-
EPS growth Chemicals: +11.7%+27.8% ★ Q1'26: +120.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%-4.9% Q1'26: -35.6% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+6.8% Q1'26: +11.4% (vs Q1'25)
-
ROIC Chemicals: +3.4%+1.9% Q1'26: +4.2% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+2.5% Q1'26: -6.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×12.71× Q1'26: 15.55× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
5.93B
est: 5.81B (+2.1%)
|
7.58B
est: 7.83B (-3.2%)
|
8.16B
est: 8.49B (-3.9%)
|
6.78B
est: 7.45B (-9.0%)
|
6.27B
est: 7.94B (-21.0%)
|
6.33B
est: 9.27B (-31.7%)
|
9.08B
9.08B – 9.08B
-2.1% YoY
|
9.64B
9.64B – 9.64B
+6.2% YoY
|
10.52B
10.52B – 10.52B
+9.1% YoY
|
| EBITDA |
1.22B
est: 986.85M (+23.5%)
|
1.64B
est: 1.33B (+23.4%)
|
1.34B
est: 1.44B (-7.2%)
|
898.67M
est: 1.26B (-28.9%)
|
817.81M
est: 1.29B (-36.8%)
|
1.09B
est: 1.51B (-28.0%)
|
1.48B
1.48B – 1.48B
-2.1% YoY
|
1.57B
1.57B – 1.57B
+6.2% YoY
|
1.72B
1.72B – 1.72B
+9.1% YoY
|
| EBIT |
880.88M
est: 557.38M (+58.0%)
|
1.17B
est: 751.27M (+55.1%)
|
784.16M
est: 814.43M (-3.7%)
|
297.57M
est: 714.12M (-58.3%)
|
234.18M
est: 633.77M (-63.0%)
|
432.12M
est: 740.64M (-41.7%)
|
725.17M
725.17M – 725.17M
-2.1% YoY
|
770.14M
770.14M – 770.14M
+6.2% YoY
|
840.45M
840.45M – 840.45M
+9.1% YoY
|
| Net Income |
640.61M
est: 606.15M (+5.7%)
|
1.09B
est: 1.18B (-7.6%)
|
866.25M
est: 1.15B (-24.8%)
|
446.12M
est: 501.45M (-11.0%)
|
234.44M
est: 240.40M (-2.5%)
|
305.71M
est: 307.18M (-0.5%)
|
663.34M
663.34M – 663.34M
+115.9% YoY
|
787.99M
787.99M – 787.99M
+18.8% YoY
|
943.81M
943.81M – 943.81M
+19.8% YoY
|
| SGA |
304.06M
est: 277.94M (+9.4%)
|
318.05M
est: 374.63M (-15.1%)
|
329.55M
est: 406.12M (-18.9%)
|
346.57M
est: 356.10M (-2.7%)
|
340.99M
est: 389.67M (-12.5%)
|
364.88M
est: 455.38M (-19.9%)
|
445.87M
445.87M – 445.87M
-2.1% YoY
|
473.52M
473.52M – 473.52M
+6.2% YoY
|
516.75M
516.75M – 516.75M
+9.1% YoY
|
| EPS |
0.48
est: 0.47 (+3.1%)
|
0.82
est: 0.91 (-9.6%)
|
0.65
est: 0.88 (-26.5%)
|
0.33
est: 0.39 (-14.3%)
|
0.18
est: 0.18 (+0.0%)
|
0.23
est: 0.23 (+0.0%)
|
0.50
0.50 – 0.50
+115.9% YoY
|
0.59
0.59 – 0.59
+18.8% YoY
|
0.71
0.71 – 0.71
+19.8% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-28 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-27 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-26 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-25 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-22 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-21 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-20 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-19 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-18 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-15 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-14 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-13 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-12 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-11 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-08 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-07 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-06 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-30 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-29 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF ASHS | 0.08% | 31.0K | 0.65% |
| 2 | WisdomTree Emerging Markets SmallCap Dividend UCITS ETF DGSD.L | 0.02% | 9.5K | 0.54% |
| 3 | KraneShares ICBCCS S&P China 500 Index UCITS ETF CHIN.L | 0.02% | 13.5K | 0.55% |
| 4 | WisdomTree Emerging Markets SmallCap Dividend Fund DGS | 0.01% | 213.1K | 0.58% |
| 5 | State Street SPDR S&P China ETF GXC | 0.01% | 48.3K | 0.59% |
| 6 | Franklin FTSE China ETF FLCH | 0.01% | 20.2K | 0.19% |
| 7 | Franklin FTSE China UCITS ETF FLXC.L | 0.01% | 93.8K | 0.19% |
| 8 | Vanguard FTSE Asia ex Japan Shares Index ETF VAE.AX | 0.00% | 22.4K | 0.40% |
| 9 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 26.9K | 0.48% |
| 10 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 60.7K | 0.26% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Fang Li | Senior Vice President & Chief Technology Officer | — | male |
| Haili Zhao | Senior Vice President, Chief Operating Officer & Director | — | male |
| Huilong Han | Senior Vice President | — | male |
| Jun Li | Senior Vice President | — | male |
| Wenquan Cai | Executive Vice President, Chief Financial Officer, Secretary of the Board & Director | — | male |
| Yaping Xie | Senior Vice President | — | male |
| Yueming Zheng | Chairman & President | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 003022.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
